A2 Biotherapeutics Inc.
Clinical trials sponsored by A2 Biotherapeutics Inc., explained in plain language.
-
Smart cell therapy aims to target advanced cancers while sparing healthy tissue
Disease control Recruiting nowThis study is testing a new type of personalized cell therapy for adults with advanced solid tumors that have returned or spread. The therapy, called Tmod CAR T cells, is designed to find and kill cancer cells while trying to avoid harming the patient's healthy cells. Researchers…
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated Apr 03, 2026 21:25 UTC
-
Smart cell therapy aims to target cancer while sparing healthy tissue
Disease control Recruiting nowThis study is testing a new type of cell therapy called A2B395 for adults with advanced solid tumors that have spread or returned. The therapy uses modified immune cells designed to specifically kill cancer cells while protecting the patient's healthy cells. The main goals are to…
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Scientists collect cancer cells to build future personalized treatments
Knowledge-focused Recruiting nowThis study is preparing for future cancer treatment trials by collecting information and materials from patients. Researchers will analyze tumor tissue from people with advanced solid tumors and collect their white blood cells through a procedure called apheresis. The collected c…
Sponsor: A2 Biotherapeutics Inc. • Aim: Knowledge-focused
Last updated Apr 03, 2026 21:25 UTC